Johnson & Johnson 

$228.65
41050
+$1.4+0.62% Today

Statistics

Day High
231.19
Day Low
227.25
52W High
231.19
52W Low
141.5
Volume
1,554,276
Avg. Volume
8,884,967
Mkt Cap
550.89B
P/E Ratio
18.25
Dividend Yield
2.29%
Dividend
5.23

Upcoming

Dividends

2.29%Dividend Yield
Dec 25
$1.3
Sep 25
$1.3
Jun 25
$1.3
Mar 25
$1.24
Dec 24
$1.24
10Y Growth
5.14%
5Y Growth
4.41%
3Y Growth
3.43%
1Y Growth
1.17%

Earnings

14AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
1.99
2.26
2.53
2.8
Expected EPS
2.685447
Actual EPS
N/A

Financials

15.84%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
177.64BRevenue
28.13BNet Income

Analyst Ratings

$232.40Average Price Target
The highest estimate is 265.00.
From 15 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JNJ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer competes directly with JNJ in the pharmaceuticals sector, offering a wide range of prescription drugs and vaccines.
Merck
MRK
Mkt Cap214.76B
Merck operates in the pharmaceutical industry, directly competing with JNJ in areas such as vaccines and prescription medications.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, a research-based biopharmaceutical company, competes with JNJ in multiple therapeutic areas, including immunology and oncology.
Novartis
NVS
Mkt Cap237.61B
Novartis competes with JNJ in the healthcare sector, particularly in pharmaceuticals, offering drugs in areas like oncology and neurology.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, areas where JNJ is also a key player.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a competitor in the pharmaceutical industry, offering prescription drugs in areas like cancer and cardiovascular diseases, similar to JNJ.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline competes with JNJ in pharmaceuticals and consumer healthcare products, including vaccines and over-the-counter medicines.
Sanofi
SNY
Mkt Cap124.45B
Sanofi competes with JNJ in the pharmaceutical sector, particularly in areas like vaccines, rare diseases, and multiple sclerosis treatments.
AMGEN
AMGN
Mkt Cap160.66B
Amgen, a biopharmaceutical company, competes with JNJ in the development of innovative therapies, particularly in oncology and cardiology.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories competes with JNJ in the medical devices and diagnostics sectors, as well as in nutritional products and generic pharmaceuticals.

About

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Show more...
CEO
Mr. Joaquin Duato
Employees
138100
Country
US
ISIN
US4781601046

Listings

0 Comments

Share your thoughts

FAQ

What is Johnson & Johnson stock price today?
The current price of JNJ is $228.65 USD — it has increased by +0.62% in the past 24 hours. Watch Johnson & Johnson stock price performance more closely on the chart.
What is Johnson & Johnson stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Johnson & Johnson stocks are traded under the ticker JNJ.
Is Johnson & Johnson stock price growing?
JNJ stock has risen by +3.48% compared to the previous week, the month change is a +10.54% rise, over the last year Johnson & Johnson has showed a +50.64% increase.
What is Johnson & Johnson market cap?
Today Johnson & Johnson has the market capitalization of 550.89B
When is the next Johnson & Johnson earnings date?
Johnson & Johnson is going to release the next earnings report on April 14, 2026.
What were Johnson & Johnson earnings last quarter?
JNJ earnings for the last quarter are 2.46 USD per share, whereas the estimation was 2.46 USD resulting in a -0.12% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Johnson & Johnson revenue for the last year?
Johnson & Johnson revenue for the last year amounts to 177.64B USD.
What is Johnson & Johnson net income for the last year?
JNJ net income for the last year is 28.13B USD.
Does Johnson & Johnson pay dividends?
Yes, JNJ dividends are paid quarterly. The last dividend per share was 1.3 USD. As of today, Dividend Yield (FWD)% is 2.29%.
How many employees does Johnson & Johnson have?
As of February 02, 2026, the company has 138,100 employees.
In which sector is Johnson & Johnson located?
Johnson & Johnson operates in the Health Care sector.
When did Johnson & Johnson complete a stock split?
The last stock split for Johnson & Johnson was on June 13, 2001 with a ratio of 2:1.
Where is Johnson & Johnson headquartered?
Johnson & Johnson is headquartered in New Brunswick, US.